Center Articles and Publications

Influenza Vaccine Production for the U.S. Market

Lauren M. Smith, Gigi Kwik Gronvall

Biosecurity and Bioterrorism. Volume 7, Number 3, 2009. © Mary Ann Liebert, Inc. doi:10.1089/bsp.2009.0921.

Introduction: Policymakers will be better prepared to formulate and communicate policies for access to influenza vaccine if they understand the vaccine production process and timeline. In addition to providing background, this article highlights where vaccine production delays may occur. This should be useful for describing vaccine production issues that may be raised by the current 2009 H1N1 pandemic..

Note: Full article available on publisher's website.

Subscribe to Biosecurity and Bioterrorism at www.liebertpub.com.